MedPath

Livionex Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

Phase 1
Completed
Conditions
Age Related Cataracts
Interventions
First Posted Date
2024-04-15
Last Posted Date
2024-04-16
Lead Sponsor
Livionex Inc.
Target Recruit Count
111
Registration Number
NCT06365762
Locations
🇺🇸

St Mary's Eye Specialists, Inc., San Francisco, California, United States

🇺🇸

Hunkeler Eye Institute, Overland Park, Kansas, United States

🇺🇸

The Johns Hopkins Hospital & Health System, Wilmer Eye Institute, Lutherville, Maryland, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.